Our Vision
- HOME
- Our Vision
- History
History
-
2023
- 01 Renamed RegenInnopharm Inc.
-
2022
- 09 Won a government grant from the Korea Drug Development Fund
(Development of a novel peptide drug to treat diabetic foot ulcer through multimodal regeneration) - 02 Registered as a government-accredited venture business
- 09 Won a government grant from the Korea Drug Development Fund
-
2021
- 09 Won a government grant from the Korea Drug Development Fund
(Development of a potent, RNA-based drug to treat acute myocardial infarction) - 05 Company-affiliated research center accredited
- 09 Won a government grant from the Korea Drug Development Fund
-
2019
- 12 Established StemMeditech Inc. as a subsidiary of Catholic Technology Holding Company